Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Heartflow, Inc. (NASDAQ:HTFL) is one of the best ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Heartflow (NASDAQ: HTFL) stock surges ~50% as the company focused on AI-driven tools for the diagnosis of heart diseases make ...

Backed by Bain Capital, the health technology startup makes 3D models of people's hearts to help diagnose diseases. Here's ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Medical technology firm Heartflow said on Thursday it had raised $316.7 million in its U.S. initial public offering, setting the stage for its Nasdaq debut in another test of investor appetite for ...

Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO market gathers momentum and outrides tariff worries. The shares opened at ...

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable ...